|
National Stock Number(NSN): 6505-01-554-6107 (6505015546107, 015546107)
| NIIN: |
01-554-6107 |
Item Name: |
PROMETHAZINE HYDROCHLORIDE INJECTION |
INC: |
09404
|
| FSC: |
6505
|
Assignment Date: |
Aug-15-2007 |
CRIT: |
X |
IIG: |
09404 |
| ISC: |
5 |
Date Standardized: |
Aug-15-2007 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Apr-01-2008 |
PMIC: |
A |
FIIG: |
|
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
|
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-512-8629 |
Item Name: |
PROMETHAZINE HYDROCHLORIDE INJECTION |
| FSC: |
6505 |
Replacement Date: |
Apr-01-2008 |
|
INC: |
09404 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
4596 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
6505NCM071756 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00703-2191-04 |
3V8D7
|
TEVA PHARMACEUTICALS USA, INC. |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
PHENERGAN HCL INJECTION |
3V8D7
|
TEVA PHARMACEUTICALS USA, INC. |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
Y |
|
M |
U |
1 |
A |
$27.00 |
PG |
|
------- |
Apr-01-2008 |
H |
| DF |
SMS |
L |
N |
M |
U |
1 |
F |
$27.00 |
PG |
|
------- |
Sep-01-2007 |
H |
| DN |
SMS |
Y |
|
M |
U |
1 |
N |
$27.00 |
PG |
|
------- |
Apr-01-2008 |
H |
| DS |
SMS |
Y |
N |
M |
U |
1 |
I |
$27.00 |
PG |
|
------- |
Apr-01-2008 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I Contains 25EA |
0 |
|
|
|
| DA |
Z |
Discontinued-Use 6505015128629 |
0 |
|
|
|
| DF |
K |
U/I Contains 25EA |
0 |
|
|
|
| DN |
K |
U/I Contains 25EA |
0 |
|
|
|
| DN |
Z |
Discontinued-Use 6505015128629 |
0 |
|
|
|
| DS |
K |
U/I Contains 25EA |
0 |
|
|
|
| DS |
Z |
Discontinued-Use 6505015128629 |
0 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AJCN |
PROTECTIVE STORAGE FEATURE |
REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
25.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE PER MILLILITER |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
25 |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
PROMETHAXINE HYDROCHLORIDE INJ 25MG/ML 1ML FILL IN 2ML VI 25S |
| FEAT |
SPECIAL FEATURES |
PYROGEN-FREE SOLUTION FOR DEEP INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION; 1 ML FILL IN A 2 ML VIAL; STORE AT RM TEMP; LIGHT SENSITIVE, PROTECT FROM LIGHT, KEEP COVERD IN A CARTON UNTIL TIME OF USE; PK/25 |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
|
Aug-15-2007 |
0 |
0 |
|
|
AM|GX |
AM|BN|GX |
| FSGM |
|
Aug-15-2007 |
0 |
0 |
|
|
GX|TT |
GX|SS|TT |
| N9BL |
|
Aug-15-2007 |
0 |
0 |
|
|
GX |
GH|GX |
|